首页> 外文期刊>The Internet Journal of Microbiology >Influenza Virus Genotypes Circulating In Central Greece During 2012-2014 And Vaccine Strain Match
【24h】

Influenza Virus Genotypes Circulating In Central Greece During 2012-2014 And Vaccine Strain Match

机译:2012-2014年希腊中部流行的流感病毒基因型与疫苗株匹配

获取原文
           

摘要

During the period 2012-2014 in central Greece, influenza A(H1N1), A(H3N2) and B virus genotypes were detected and isolated from individuals with influenza illness. Influenza A(H1N1) and A (H3N2) viruses were the dominant virus type in circulation as it was detected in 9% and 12% of pharyngeal swabs examined by real-time RT-PCR during both seasons, respectively, while type B viruses were detected in only 3% of the samples examined. Influenza activity in central Greece, as was determined by number of reported influenza cases and influenza positive samples detected, was markedly increased in the 2013-14, as compared to the 2012-13 season. Influenza A(H1N1)pdm09 viruses were detected during the 2013-14 season along with A (H3N2) and type B viruses. All type A(H1N1), A (H3N2) and type B influenza isolates analyzed by cell culture reacted to a high titer (> 640) against antisera to vaccine-like viruses of the same period, indicating satisfactory influenza vaccine protection against circulating seasonal and pandemic influenza viral strains. Introduction Influenza type A and B viruses possess a segmented RNA genome which promotes the periodic emergence of influenza viral variants responsible for influenza epidemics and significant disease burden in the community. (1, 2). The surface antigens of influenza viruses, the hemagglutinin (HA) and neuraminidase (NA) are under selective pressure from the host immune system, constituting the basic mechanism of antigenic drift evident in influenza viruses (3, 4 )Influenza surveillance programs aim to reduce the impact of influenza by efficient vaccination programs. Global influenza activity is associated with increased morbidity and mortality indices due mainly to complications that result from infection, especially among individuals belonging to the high-risk groups (2, 5). Yearly vaccination with the trivalent influenza vaccine is recommended at the beginning of the influenza season in order to reduce the impact of the disease in the community (7).The present study reports laboratory data relating to influenza virus molecular epidemiology in central Greece and constitutes the first systematic survey of influenza viruses in central Greece. Materials and Methods Clinical specimenDuring the period 2012-14 a total of 865 pharyngeal swabs were collected from non-vaccinated individuals of all ages based on the gravity of symptoms associated with influenza-like illness (ILI), 3-4 days following the onset of symptoms, which included high fever (>38.50C), arthrralgia, myalgia, cough, headache, general malaise. Sampling took place during the influenza season in Greece from December to April, each year by health professionals at the University Hospital and by physicians of the sentinel network, Larissa, Thessaly, Greece. Sample storage and transport was accomplished in virus transport medium (24,9 gr bacto-tryptose, 5 gr gelatin, 0,5 gr streptomycin, 500,000 U penicilin and 50 mg fungizone) per liter. Storage was at +40C for up to 4 days. Long-term storage of the clinical samples was at -70oC.Real-time RT-PCR (rt-RT-PCR)Total RNA was extracted from 200ml of processed clinical sample with TRIzol (Gibco BRL, Life Technologies, NY, USA), according to manufacturer’s recommendations, in the presence of 20mg glycogen, molecular biology grade (Boehringer, Germany). Reactions in real-time RT-PCR were performed in a 7500 Applied Biosystem thermocycler, at a total reaction volume of 25μl (including 6.5μl RNA). Five different master mixes were prepared for each sample (influenza A, influenza B, H1, H3 and internal control). Forty reaction cycles were performed as follows: 450C for 10 sec, 950C for 10 min and 720C for 1min. Primers and probes used in the rt-RT-PCR reactions are shown in Table 1.Virus isolation and identificationFollowing screening by real-time RT-PCR, all positive samples were inoculated into sensitive Mardin-Darby Canine Kidney (MDCK) cell culture and incubated at 37oC for 7-10 days, as previously
机译:在希腊中部2012-2014年期间,从患有流感的个体中检出并分离出A(H1N1),A(H3N2)和B型流感病毒基因型。在两个季节中,分别通过实时RT-PCR检测到的9%和12%的咽拭子中分别检测到甲型(H1N1)和甲型(H3N2)流感病毒,而B型病毒则分别为仅在3%的被检样品中检测到。根据报告的流感病例数和检测到的流感阳性样本确定,希腊中部的流感活动在2013-14年度比2012-13年度明显增加。在2013-14年度期间,检测到了甲型(H1N1)pdm09流感病毒以及甲型(H3N2)和B型病毒。通过细胞培养分析的所有A型(H1N1),A型(H3N2)和B型流感病毒分离物均对同一时期的疫苗样病毒产生了高滴度(> 640)的抗血清反应,表明令人满意的流感疫苗对季节性和季节性流感的保护作用令人满意大流行性流感病毒株。引言甲型和乙型流感病毒具有分段的RNA基因组,可促进流感病毒变异体的周期性出现,从而引起社区中的流感流行和重大疾病负担。 (1、2)。流感病毒的表面抗原,血凝素(HA)和神经氨酸酶(NA)受宿主免疫系统的选择性压力,构成流感病毒中明显的抗原漂移的基本机制(3,4)。有效的疫苗接种计划对流感的影响。全球流行性感冒活动与发病率和死亡率指数增加有关,这主要归因于感染引起的并发症,特别是在属于高危人群的个体中(2、5)。建议在流感季节开始时每年接种三价流感疫苗,以减少疾病对社区的影响(7)。本研究报告了希腊中部有关流感病毒分子流行病学的实验室数据,希腊中部首次对流感病毒进行系统调查。材料和方法临床标本在2012-14年期间,根据与流感样疾病(ILI)相关的症状的严重程度,在感染后3-4天内,从所有年龄的未接种疫苗的个体中收集了865个咽拭子。症状,包括高烧(> 38.50C),关节痛,肌痛,咳嗽,头痛,全身不适。每年12月至4月,在希腊的流感季节,每年由大学医院的卫生专业人员和希腊色萨利拉里萨的哨兵网络的医生进行采样。样品的储存和运输是在每升病毒运输培养基(24,9克细菌-色氨酸,5克明胶,0.5克链霉素,500,000 U青霉素和50毫克真菌区)中完成的。在+ 40℃下储存最多4天。临床样品的长期储存温度为-70oC。实时RT-PCR(rt-RT-PCR)用TRIzol(Gibco BRL,Life Technologies,NY,USA)从200ml处理过的临床样品中提取总RNA。根据制造商的建议,存在20 mg糖原时,分子生物学级(德国勃林格)。在7500 Applied Biosystem热循环仪中进行实时RT-PCR反应,反应总量为25μl(包括6.5μlRNA)。为每个样品准备了五种不同的预混液(甲型流感,乙型流感,H1,H3和内部对照)。如下进行四十个反应循环:450℃10秒,950℃10分钟,720℃1分钟。 rt-RT-PCR反应中使用的引物和探针显示在表1中。与以前一样,在37oC下7-10天

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号